APOE and diabetes mellitus: APOE ɛ4 carriers with T2D had a 48% increased risk of acquiring dementia compared to APOE ɛ4 carriers without diabetes, as shown in Fig. 2 (HR: 1.48, 95% CI 1.36–1.60).